FDA Finalizing Notice-To-Industry Policy, Amid Concerns

Device makers see benefit in FDA’s plan to issue “notice to industry” letters when it wants to communicate policy changes quickly, but industry reps emphasize that FDA should not overuse the approach.

More from Archive

More from Medtech Insight